MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ADC Therapeutics SA (ADCT) Ownership - Who owns ADC Therapeutics SA?

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

Profile

Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
268.91M
P/E Ratio
N/A
Total Cash
194.7M
Projected Growth
N/A
Total Debt
123.1M
Revenue
75.82M
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
1.96
Total Debt/Equity
N/A
Revenue/Share
0.73 USD as % of share price

Fundamentals

ADCT
Capitalization
269M
P/E Ratio
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
195M
Total Cash/Share
1.96
Total Debt
123M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.73%
Revenue
75.8M
ROE
N/A
Book Value
-238.22M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.44M
Current Ratio
4.46
Current Revenue Per Employee
87577.95
Dividends Per Share - Security
N/A
EBITDA
-95.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.05
Revenue To Assets
-51.62
Shares Held By Institutions
111M
Shares Outstanding - Current
99.2M
Total Liabilities
511M
Total Volume MTD
N/A
Value
N/A
Gain YTD
36.181
View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com